Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 130
1.
Lancet Oncol ; 23(2): e62-e74, 2022 02.
Article En | MEDLINE | ID: mdl-35114133

With increasing attention on the essential roles of the tumour microenvironment in recent years, the nervous system has emerged as a novel and crucial facilitator of cancer growth. In this Review, we describe the foundational, translational, and clinical advances illustrating how nerves contribute to tumour proliferation, stress adaptation, immunomodulation, metastasis, electrical hyperactivity and seizures, and neuropathic pain. Collectively, this expanding knowledge base reveals multiple therapeutic avenues for cancer neuroscience that warrant further exploration in clinical studies. We discuss the available clinical data, including ongoing trials investigating novel agents targeting the tumour-nerve axis, and the therapeutic potential for repurposing existing neuroactive drugs as an anti-cancer approach, particularly in combination with established treatment regimens. Lastly, we discuss the clinical challenges of these treatment strategies and highlight unanswered questions and future directions in the burgeoning field of cancer neuroscience.


Neoplasms/drug therapy , Neurosciences , Cancer Pain/drug therapy , Clinical Trials as Topic , Drug Resistance, Neoplasm , Humans , Immune Checkpoint Inhibitors/therapeutic use , Neoplasms/etiology , Neoplasms/immunology , Neoplasms/pathology , Nervous System Physiological Phenomena/drug effects , Tumor Microenvironment
2.
Toxins (Basel) ; 13(9)2021 09 16.
Article En | MEDLINE | ID: mdl-34564664

Cyanobacteria are capable of producing a wide range of bioactive compounds with many considered to be toxins. Although there are a number of toxicological outcomes with respect to cyanobacterial exposure, this review aims to examine those which affect the central nervous system (CNS) or have neurotoxicological properties. Such exposures can be acute or chronic, and we detail issues concerning CNS entry, detection and remediation. Exposure can occur through a variety of media but, increasingly, exposure through air via inhalation may have greater significance and requires further investigation. Even though cyanobacterial toxins have traditionally been classified based on their primary mode of toxicity, increasing evidence suggests that some also possess neurotoxic properties and include known cyanotoxins and unknown compounds. Furthermore, chronic long-term exposure to these compounds is increasingly being identified as adversely affecting human health.


Cyanobacteria Toxins/toxicity , Cyanobacteria/chemistry , Nervous System Physiological Phenomena/drug effects , Humans
3.
Br J Anaesth ; 125(1): e140-e147, 2020 07.
Article En | MEDLINE | ID: mdl-32241547

BACKGROUND: We hypothesised that Calabadion 1, an acyclic cucurbit[n]uril molecular container, reverses fentanyl-induced respiratory depression and dysfunction of the CNS. METHODS: Experiments were conducted in male Sprague-Dawley rats. A constant-rate i.v. infusion of fentanyl (12.5 or 25 µg kg-1 over 15 min) was administered followed by an i.v. bolus of Calabadion 1 (0.5-200 mg kg-1) or placebo. The primary outcome was reversal of ventilatory and respiratory depression, assessed by pneumotachography and arterial blood gas analysis, respectively. Key secondary outcomes were effects on fentanyl-induced central nervous dysfunction quantified by righting reflex, balance beam test, and electromyography (EMG). RESULTS: Calabadion 1 reversed fentanyl-induced respiratory depression across the endpoints minute ventilation, pH, and Paco2 (P=0.001). Compared with placebo, Calabadion 1 dose dependently (P for trend <0.001) reversed fentanyl-induced hypoventilation {81.9 [5.1] (mean [standard error of the mean]) vs 45.5 [12.4] ml min-1; P<0.001}, acidosis (pH 7.43 [0.01] vs 7.28 [0.04]; P=0.005), and hypercarbia (Paco2 43.4 [1.6] vs 63.4 [8.1] mm Hg; P=0.018). The effective Calabadion 1 doses required to reverse respiratory depression by 50% and 90% (ED50Res and ED90Res) were 1.7 and 15.6 mg kg-1, respectively. Higher effective doses were needed for recovery of righting reflex (ED50CNS: 9.6 mg kg-1; ED90CNS: 86.1 mg kg-1), which was accelerated by Calabadion 1 (4.6 [0.3] vs 9.0 [0.7] min; P<0.001). Calabadion 1 also significantly accelerated recovery of full functional mobility and reversal of muscle rigidity. CONCLUSIONS: Calabadion 1 selectively and dose dependently reversed the respiratory system and CNS side-effects of fentanyl.


Analgesics, Opioid/adverse effects , Fentanyl/adverse effects , Heterocyclic Compounds, 4 or More Rings/pharmacology , Nervous System Physiological Phenomena/drug effects , Respiratory Insufficiency/chemically induced , Respiratory Insufficiency/prevention & control , Sulfonic Acids/pharmacology , Animals , Disease Models, Animal , Male , Rats , Rats, Sprague-Dawley
4.
Rev Neurol (Paris) ; 175(10): 693-697, 2019 Dec.
Article En | MEDLINE | ID: mdl-31627893

Japan provides many lessons for the Environmental Neurology's issues. Drama and disasters have paved the recent history of Japan. The Japanese people have been intoxicated by chemical compounds (methylmercury, sulfur dioxide, cadmium, PCBs and other dioxin-related compounds) and were the victims of several dramatic disasters (atomic bombing, nuclear disaster, sarin gas attack). They are still exposed to air pollution. Prion diseases including dura-graft-associated CJD are still an issue. In addition, continuously spreading chronic wasting disease is a worldwide challenge .


Brain Diseases , Brain/physiology , Environment , Nervous System Physiological Phenomena , Brain/drug effects , Brain Diseases/chemically induced , Brain Diseases/epidemiology , Environmental Pollutants/toxicity , Fukushima Nuclear Accident , History, 20th Century , History, 21st Century , Humans , Japan/epidemiology , Nervous System/drug effects , Nervous System Physiological Phenomena/drug effects , Sarin/toxicity
5.
Nat Commun ; 10(1): 2620, 2019 06 13.
Article En | MEDLINE | ID: mdl-31197165

Conventional drug screens and treatments often ignore the underlying complexity of brain network dysfunctions, resulting in suboptimal outcomes. Here we ask whether we can correct abnormal functional connectivity of the entire brain by identifying and combining multiple neuromodulators that perturb connectivity in complementary ways. Our approach avoids the combinatorial complexity of screening all drug combinations. We develop a high-speed platform capable of imaging more than 15000 neurons in 50ms to map the entire brain functional connectivity in large numbers of vertebrates under many conditions. Screening a panel of drugs in a zebrafish model of human Dravet syndrome, we show that even drugs with related mechanisms of action can modulate functional connectivity in significantly different ways. By clustering connectivity fingerprints, we algorithmically select small subsets of complementary drugs and rapidly identify combinations that are significantly more effective at correcting abnormal networks and reducing spontaneous seizures than monotherapies, while minimizing behavioral side effects. Even at low concentrations, our polytherapy performs superior to individual drugs even at highest tolerated concentrations.


Epilepsies, Myoclonic/drug therapy , Models, Biological , Nerve Net/drug effects , Nervous System Physiological Phenomena/drug effects , Neurotransmitter Agents/pharmacology , Algorithms , Animals , Animals, Genetically Modified , Behavior, Animal/drug effects , Brain/cytology , Brain/diagnostic imaging , Brain/drug effects , Brain/physiology , Brain Mapping/methods , Disease Models, Animal , Drug Evaluation, Preclinical/methods , Drug Synergism , Drug Therapy, Combination/methods , Epilepsies, Myoclonic/genetics , Epilepsies, Myoclonic/pathology , High-Throughput Screening Assays/methods , Humans , Microscopy, Confocal/methods , Nerve Net/diagnostic imaging , Nerve Net/physiology , Neurons/drug effects , Neurons/physiology , Neurotransmitter Agents/therapeutic use , Zebrafish
6.
Respir Physiol Neurobiol ; 266: 95-102, 2019 08.
Article En | MEDLINE | ID: mdl-31055189

Spinal phrenic nerve activity (PNA) drives the diaphragm but cranial hypoglossal nerve activity (HNA) also expresses synchronous activity during inspiration. Here, we investigated the effects of local disinhibition (bilateral microinjections of bicuculline) of the nucleus tractus solitarius (NTS), the pre-Bötzinger complex and Bötzinger complex core circuit (pre-BötC/BötC) and the Kölliker-Fuse nuclei (KFn) on the synchronization of PNA and HNA in arterially-perfused brainstem preparations of rats. To quantitatively analyze the bicuculline effects on a putatively distributed inspiratory central pattern generator (i-CPG), we quantified the phase synchronization properties between PNA and HNA. The analysis revealed that bicuculline-evoked local disinhibition significantly reduced the strength of phase synchronization between PNA and HNA at any target site. However, the emergence of desynchronized HNA following disinhibition was more prevalent after NTS or pre-BötC/BötC microinjections compared to the KFn. We conclude that the primary i-CPG is located in a distributed medullary circuit whereas pontine contributions are restricted to synaptic gating of synchronous HNA and PNA.


Central Pattern Generators/physiology , Kolliker-Fuse Nucleus/physiology , Medulla Oblongata/physiology , Nerve Net/physiology , Nervous System Physiological Phenomena , Phrenic Nerve/physiology , Respiration , Solitary Nucleus/physiology , Animals , Bicuculline/pharmacology , Central Pattern Generators/drug effects , Female , GABA-A Receptor Antagonists/pharmacology , Kolliker-Fuse Nucleus/drug effects , Male , Medulla Oblongata/drug effects , Nerve Net/drug effects , Nervous System Physiological Phenomena/drug effects , Phrenic Nerve/drug effects , Rats , Rats, Sprague-Dawley , Solitary Nucleus/drug effects
7.
Chemosphere ; 229: 169-180, 2019 Aug.
Article En | MEDLINE | ID: mdl-31078031

Although silver nanoparticles (AgNPs) are used in various commercial products, the biological effects of AgNPs on fish embryogenesis and the underlying molecular mechanisms are still poorly understood. In this study, both touch responses and neuron membrane potential were found to be abnormal in AgNPs-stressed embryos. Moreover, neurogenesis genes were unveiled to be down-regulated and were enriched in ligand-gated ion channel activity, dopamine receptor signaling pathway, etc. in AgNPs-stressed embryos by microarray assays. Additionally, the down-regulated expression of otpa/sncgb - gad1b/gad2 dopaminergic neurotransmitter genes, robo2 - vim and glrbb synaptic transmission genes, and motor neuron genes isl1 &isl2a was further identified in both AgNPs- and Ag+-stressed embryos by qPCR, whole-mount in situ hybridization (WISH), and by using specific promoter-derived GFP fluorescence transgenic zebrafish. Moreover, the reduced expression of gad1b, gad2, and isl1 could be recovered by adding Ag+ chelating compound l-cysteine in AgNPs stressed embryos. Our results reveal for the first time that it is through damaging the formation of neural circuits, including dopaminergic neurotransmitter, synaptic transmission, and motor activities, that AgNPs induce abnormal electrical membrane properties, leading to dysfunctional touch responses and locomotor escape responses mostly via their released Ag+ during embryogenesis.


Embryo, Nonmammalian/drug effects , Metal Nanoparticles/toxicity , Nervous System Physiological Phenomena/drug effects , Silver/chemistry , Silver/toxicity , Touch/drug effects , Zebrafish/embryology , Animals , Embryo, Nonmammalian/physiology , Touch/physiology , Zebrafish/metabolism , Zebrafish/physiology , Zebrafish Proteins/genetics , Zebrafish Proteins/metabolism
8.
Aquat Toxicol ; 210: 44-55, 2019 May.
Article En | MEDLINE | ID: mdl-30822702

Intraspecies variation is common in both clinical and animal research of various brain disorders. Relatively well-studied in mammals, intraspecies variation in aquatic fish models and its role in their behavioral and pharmacological responses remain poorly understood. Like humans and mammals, fishes show high variance of behavioral and drug-evoked responses, modulated both genetically and environmentally. The zebrafish (Danio rerio) has emerged as a particularly useful model organism tool to access neurobehavioral and drug-evoked responses. Here, we discuss recent findings and the role of the intraspecies variance in neurobehavioral, pharmacological and toxicological studies utilizing zebrafish and other fish models. We also critically evaluate common sources of intraspecies variation and outline potential strategies to improve data reproducibility and translatability.


Behavior, Animal/drug effects , Nervous System Physiological Phenomena/drug effects , Water Pollutants, Chemical/toxicity , Zebrafish/physiology , Animals , Gene-Environment Interaction , Humans , Models, Biological , Nervous System Physiological Phenomena/genetics , Phenotype , Reproducibility of Results , Sex Characteristics , Species Specificity , Zebrafish/genetics
9.
Horm Behav ; 111: 7-22, 2019 05.
Article En | MEDLINE | ID: mdl-30476496

A contribution to SBN/ICN special issue. Endocrine-disrupting chemicals (EDCs) are pervasive in the environment. They are found in plastics and plasticizers (bisphenol A (BPA) and phthalates), in industrial chemicals such as polychlorinated biphenyls (PCBs), and include some pesticides and fungicides such as vinclozolin. These chemicals act on hormone receptors and their downstream signaling pathways, and can interfere with hormone synthesis, metabolism, and actions. Because the developing brain is particularly sensitive to endogenous hormones, disruptions by EDCs can change neural circuits that form during periods of brain organization. Here, we review the evidence that EDCs affect developing hypothalamic neuroendocrine systems, and change behavioral outcomes in juvenile, adolescent, and adult life in exposed individuals, and even in their descendants. Our focus is on social, communicative and sociosexual behaviors, as how an individual behaves with a same- or opposite-sex conspecific determines that individual's ability to exist in a community, be selected as a mate, and reproduce successfully.


Endocrine Disruptors/pharmacology , Nervous System/drug effects , Neurosecretory Systems/drug effects , Social Behavior , Adolescent , Adult , Animals , Child , Environmental Pollutants/pharmacology , Humans , Nervous System Physiological Phenomena/drug effects , Reproduction/drug effects
10.
J Vis Exp ; (141)2018 11 21.
Article En | MEDLINE | ID: mdl-30531714

The majority of the currently available insecticides target the nervous system and genetic mutations of invertebrate neural proteins oftentimes yield deleterious consequences, yet the current methods for recording nervous system activity of an individual animal is costly and laborious. This suction electrode preparation of the third-instar larval central nervous system of Drosophila melanogaster, is a tractable system for testing the physiological effects of neuroactive agents, determining the physiological role of various neural pathways to CNS activity, as well as the influence of genetic mutations to neural function. This ex vivo preparation requires only moderate dissecting skill and electrophysiological expertise to generate reproducible recordings of insect neuronal activity. A wide variety of chemical modulators, including peptides, can then be applied directly to the nervous system in solution with the physiological saline to measure the influence on the CNS activity. Further, genetic technologies, such as the GAL4/UAS system, can be applied independently or in tandem with pharmacological agents to determine the role of specific ion channels, transporters, or receptors to arthropod CNS function. In this context, the assays described herein are of significant interest to insecticide toxicologists, insect physiologists, and developmental biologists for which D. melanogaster is an established model organism. The goal of this protocol is to describe an electrophysiological method to enable the measurement of electrogenesis of the central nervous system in the model insect, Drosophila melanogaster, which is useful for testing a diversity of scientific hypotheses.


Central Nervous System/physiology , Drosophila melanogaster/physiology , Larva/physiology , Animals , Central Nervous System/drug effects , Dissection/methods , Dose-Response Relationship, Drug , Drosophila melanogaster/drug effects , Extracellular Fluid/drug effects , Extracellular Fluid/physiology , Insecticides/pharmacology , Larva/drug effects , Microscopy/methods , Models, Animal , Nervous System Physiological Phenomena/drug effects , Neurons/drug effects , Neurons/physiology
11.
Environ Int ; 121(Pt 2): 1331-1340, 2018 12.
Article En | MEDLINE | ID: mdl-30420132

BACKGROUND: Oxidative stress and inflammation are considered to be important pathways leading to particulate matter (PM)-associated disease. In this exploratory study, we examined the effects of metals and oxidative potential (OP) in urban PM on biomarkers of systemic inflammation, oxidative stress and neural function. METHODS: Fifty-three healthy non-smoking volunteers (mean age 28 years, twenty-eight females) were exposed to coarse (2.5-10 µm, mean 213 µg/m3), fine (0.15-2.5 µm, 238 µg/m3), and/or ultrafine concentrated ambient PM (<0.3 µm, 136 µg/m3). Exposures lasted 130 min, separated by ≥2 weeks. Metal concentrations and OP (measured by ascorbate and glutathione depletion in synthetic airway fluid) in PM were analyzed. Blood and urine samples were collected pre-exposure, and 1-h and 21-h post exposure for assessment of biomarkers. We used mixed-regression models to analyze associations adjusting for PM size and mass concentration. RESULTS: Results for metals were expressed as change (%) from daily pre-exposure biomarker levels after exposure to a metal at a level equivalent to the mean concentration. Exposure to various metals (silver, aluminum, barium, copper, iron, potassium, lithium, nickel, tin, and/or vanadium) was significantly associated with increased levels of various blood or urinary biomarkers. For example, the blood inflammatory marker vascular endothelia growth factor (VEGF) increased 5.3% (95% confidence interval: 0.3%, 10.2%) 1-h post exposure to nickel; the traumatic brain injury marker ubiquitin C-terminal hydrolase L1 (UCHL1) increased 11% (1.2%, 21%) and 14% (0.3%, 29%) 1-h and 21-h post exposure to barium, respectively; and the systemic stress marker cortisol increased 1.5% (0%, 2.9%) and 1.5% (0.5%, 2.8%) 1-h and 21-h post exposure to silver, respectively. Urinary DNA oxidation marker 8­hydroxy­deoxy­guanosine increased 14% (6.4%, 21%) 1-h post exposure to copper; urinary neural marker vanillylmandelic acid increased 29% (3%, 54%) 1-h post exposure to aluminum; and urinary cortisol increased 88% (0.9%, 176%) 1-h post exposure to vanadium. Results for OP were expressed as change (%) from daily pre-exposure biomarker levels after exposure to ascorbate-related OP at a level equivalent to the mean concentration, or for exposure to glutathione-related OP at a level above the limit of detection. Exposure to ascorbate- or glutathione-related OP was significantly associated with increased inflammatory and neural biomarkers including interleukin-6, VEGF, UCHL1, and S100 calcium-binding protein B in blood, and malondialdehyde and 8-hydroxy-deoxy-guanosine in urine. For example, UCHL1 increased 9.4% (1.8%, 17%) in blood 21-h post exposure to ascorbate-related OP, while urinary malondialdehyde increased 19% (3.6%, 35%) and 8-hydroxy-deoxy-guanosine increased 24% (2.9%, 48%) 21-h post exposure to ascorbate- and glutathione-related OP, respectively. CONCLUSION: Our results from this exploratory study suggest that metal constituents and OP in ambient PM may influence biomarker levels associated with systemic inflammation, oxidative stress, perturbations of neural function, and systemic physiological stress.


Air Pollutants , Inflammation/chemically induced , Inhalation Exposure/adverse effects , Metals , Oxidants , Particulate Matter/adverse effects , Adult , Air Pollutants/blood , Air Pollutants/urine , Biomarkers/blood , Biomarkers/urine , Female , Humans , Male , Metals/blood , Metals/urine , Middle Aged , Nervous System Physiological Phenomena/drug effects , Ontario , Oxidants/blood , Oxidants/urine , Oxidative Stress , Young Adult
12.
Br J Anaesth ; 121(1): 86-94, 2018 Jul.
Article En | MEDLINE | ID: mdl-29935600

BACKGROUND: Transitions into and out of the anaesthetised state exhibit resistance to state transitions known as neural inertia. As a consequence, emergence from anaesthesia occurs at a consistently lower anaesthetic concentration than induction. Motivated by stochastic switching between discrete activity patterns observed at constant anaesthetic concentration, we investigated the consequences of such switching for neural inertia. METHODS: We simulated stochastic switching in MATLAB as Brownian motion on an energy landscape or equivalently as a discrete Markov process. Effects of anaesthetics were modelled as changing stability of the awake and the anaesthetised states. Simulation results were compared with re-analysed neural inertia data from mice and Drosophila. RESULTS: Diffusion on a two-well energy landscape gives rise to hysteresis. With additive noise, hysteresis collapses. This collapse occurs over a mixing time that is independent from pharmacokinetics. The two-well potential gives rise to the leftward shift for the emergence dose-response curve. Yet, from in vivo data, ΔEC50 and Δ Hill slope are strongly negatively correlated (R2=0.45, P<1.7×10-15). This correlation is not explained by a two-well potential. The extension of the diffusion model to a Markov process with 10 states (three awake, seven unconscious) reproduces both the left shift and the shallower Hill slope for emergence. CONCLUSIONS: Stochastic state switching accounts for all known features of neural inertia. More than two states are required to explain the consistent increase observed in variability of recovery from general anaesthesia. This model predicts that hysteresis should collapse with a time scale independent of anaesthetic drug pharmacokinetics.


Anesthesia Recovery Period , Anesthesia, General , Nervous System Physiological Phenomena/drug effects , Stochastic Processes , Algorithms , Anesthetics/pharmacokinetics , Anesthetics/pharmacology , Computer Simulation , Electroencephalography , Humans , Markov Chains , Models, Theoretical
13.
Neurochem Res ; 43(6): 1191-1199, 2018 Jun.
Article En | MEDLINE | ID: mdl-29740748

Amitriptyline is a commonly used tricyclic antidepressant (TCA) inhibiting serotonin and norepinephrine reuptake. The exact CNS action of TCAs remains poorly understood, necessitating new screening approaches and novel model organisms. Zebrafish (Danio rerio) are rapidly emerging as a promising tool for pharmacological research of antidepressants, including amitriptyline. Here, we examine the effects of chronic 2-week exposure to 10 and 50 µg/L amitriptyline on zebrafish behavior and monoamine neurotransmitters. Overall, the drug at 50 µg/L evoked pronounced anxiolytic-like effects in the novel tank test (assessed by more time in top, fewer transition and shorter latency to enter the top). Like other TCAs, amitriptyline reduced serotonin turnover, but also significantly elevated whole-brain norepinephrine and dopamine levels. The latter effect was not reported in this model previously, and accompanied higher brain expression of tyrosine hydroxylase (a rate-limiting enzyme of catecholamine biosynthesis), but unaltered expression of dopamine-ß-hydroxylase and monoamine oxidase (the enzymes of dopamine metabolism). This response may underlie chronic amitriptyline action on dopamine and norepinephrine neurotransmission, and contribute to the complex CNS profile of this drug observed both clinically and in animal models. Collectively, these findings also confirm the important role of monoamine modulation in the regulation of anxiety-related behavior in zebrafish, and support the utility of this organism as a promising in-vivo model for CNS drug screening.


Antidepressive Agents/pharmacology , Behavior, Animal/drug effects , Brain/drug effects , Synaptic Transmission/drug effects , Animals , Anti-Anxiety Agents/pharmacology , Antidepressive Agents, Tricyclic/pharmacology , Brain/metabolism , Nervous System Physiological Phenomena/drug effects , Neurochemistry/methods , Norepinephrine/metabolism , Tyrosine 3-Monooxygenase/metabolism , Zebrafish
14.
Br J Nutr ; 119(11): 1312-1323, 2018 06.
Article En | MEDLINE | ID: mdl-29580307

The current paradigms of prevention and treatment are unable to curb obesity rates, which indicates the need to explore alternative therapeutic approaches. Obesity leads to several damages to the body and is an important risk factor for a number of other chronic diseases. Furthermore, despite the first alterations in obesity being observed and reported in peripheral tissues, studies indicate that obesity can also cause brain damage. Obesity leads to a chronic low-grade inflammatory state, and the therapeutic manipulation of inflammation can be explored. In this context, the use of n-3 PUFA (especially in the form of fish oil, rich in EPA and DHA) may be an interesting strategy, as this substance is known by its anti-inflammatory effect and numerous benefits to the body, such as reduction of TAG, cardiac arrhythmias, blood pressure and platelet aggregation, and has shown potential to help treat obesity. Thereby, the aim of this narrative review was to summarise the literature related to n-3 PUFA use in obesity treatment. First, the review provides a brief description of the obesity pathophysiology, including alterations that occur in peripheral tissues and at the central nervous system. In the sequence, we describe what are n-3 PUFA, their sources and their general effects. Finally, we explore the main topic linking obesity and n-3 PUFA. Animal and human studies were included and alterations on the whole organism were described (peripheral tissues and brain).


Fatty Acids, Omega-3/administration & dosage , Nervous System Physiological Phenomena/drug effects , Obesity/prevention & control , Humans , Risk Factors
15.
Sci Rep ; 7(1): 11458, 2017 09 13.
Article En | MEDLINE | ID: mdl-28904364

Caffeine is a widely consumed psychoactive substance, but little is known about the effects of caffeine stimulation on global gene expression changes in neurons. Here, we conducted gene expression profiling of human neuroepithelial stem cell-derived neurons, stimulated with normal consumption levels of caffeine (3 µM and 10 µM), over a period of 9 h. We found dosage-dependent activation of immediate early genes after 1 h. Neuronal projection development processes were up-regulated and negative regulation of axon extension processes were down-regulated at 3 h. In addition, genes involved in extracellular matrix organization, response for wound healing, and regulation of immune system processes were down-regulated by caffeine at 3 h. This study identified novel genes within the neuronal projection guidance pathways that respond to acute caffeine stimulation and suggests potential mechanisms for the effects of caffeine on neuronal cells.


Caffeine/administration & dosage , Central Nervous System Stimulants/administration & dosage , Nervous System Physiological Phenomena/drug effects , Nervous System Physiological Phenomena/genetics , Neurites/drug effects , Neurites/metabolism , Neurons/drug effects , Neurons/metabolism , Transcriptome , Biomarkers , Cell Differentiation , Cells, Cultured , Computational Biology/methods , Dose-Response Relationship, Drug , Fluorescent Antibody Technique , Gene Expression Profiling , Gene Expression Regulation/drug effects , Humans , Molecular Sequence Annotation , Neural Stem Cells/drug effects , Neural Stem Cells/metabolism , Neurogenesis/drug effects , Neurogenesis/genetics , Neurons/cytology , Phenotype
16.
Pharmacol Rev ; 69(4): 396-478, 2017 10.
Article En | MEDLINE | ID: mdl-28931622

Connexins are ubiquitous channel forming proteins that assemble as plasma membrane hemichannels and as intercellular gap junction channels that directly connect cells. In the heart, gap junction channels electrically connect myocytes and specialized conductive tissues to coordinate the atrial and ventricular contraction/relaxation cycles and pump function. In blood vessels, these channels facilitate long-distance endothelial cell communication, synchronize smooth muscle cell contraction, and support endothelial-smooth muscle cell communication. In the central nervous system they form cellular syncytia and coordinate neural function. Gap junction channels are normally open and hemichannels are normally closed, but pathologic conditions may restrict gap junction communication and promote hemichannel opening, thereby disturbing a delicate cellular communication balance. Until recently, most connexin-targeting agents exhibited little specificity and several off-target effects. Recent work with peptide-based approaches has demonstrated improved specificity and opened avenues for a more rational approach toward independently modulating the function of gap junctions and hemichannels. We here review the role of connexins and their channels in cardiovascular and neurovascular health and disease, focusing on crucial regulatory aspects and identification of potential targets to modify their function. We conclude that peptide-based investigations have raised several new opportunities for interfering with connexins and their channels that may soon allow preservation of gap junction communication, inhibition of hemichannel opening, and mitigation of inflammatory signaling.


Cardiovascular Diseases/physiopathology , Connexins/antagonists & inhibitors , Connexins/physiology , Nervous System Diseases/physiopathology , Animals , Cardiovascular Diseases/drug therapy , Cardiovascular Physiological Phenomena/drug effects , Humans , Nervous System Diseases/drug therapy , Nervous System Physiological Phenomena/drug effects
17.
Steroids ; 125: 33-36, 2017 09.
Article En | MEDLINE | ID: mdl-28636872

We examined whether hydrocortisone exposure≤1week in very low birth weight infants (VLBWI) was associated with poor neurodevelopmental outcomes at corrected 18months. Further, the clinical factors associated with worse long term outcome were also evaluated. Of a total of 191 VLBWI, the clinical data for these infants relating were retrospectively collected for analysis. Among the 191 VLBWI, 115 (60.2%) infants were exposed to early postnatal hydrocortisone≤1week of life in our NICU of Seoul St. Mary's Hospital, The Catholic University of Korea between December 2012 and December 2014. The morbidities were significantly higher in the group with early hydrocortisone exposure group. At corrected age of 18months, 109/183 (59.6%) infants in the early hydrocortisone exposure group had significantly lower scores in all three (cognitive, language and motor) composites of Bayley Scales of Infant and Toddler Development III. The multivariable logistic regression analysis showed that only periventricular leukomalacia (PVL) is consistently associated with poor long-term outcomes. Our results suggest that early hydrocortisone exposure≤1week in VLBWI may not increase the risk for poor long-term outcomes compared to those not exposed. Only PVL is considered as a risk factor for poor long-term neurodevelopmental outcomes.


Infant, Very Low Birth Weight/physiology , Nervous System Physiological Phenomena/drug effects , Steroids/adverse effects , Female , Humans , Infant, Newborn , Infant, Very Low Birth Weight/growth & development , Male , Time Factors
18.
Anesthesiology ; 127(1): 58-69, 2017 07.
Article En | MEDLINE | ID: mdl-28486269

BACKGROUND: Previous studies have demonstrated inconsistent neurophysiologic effects of ketamine, although discrepant findings might relate to differences in doses studied, brain regions analyzed, coadministration of other anesthetic medications, and resolution of the electroencephalograph. The objective of this study was to characterize the dose-dependent effects of ketamine on cortical oscillations and functional connectivity. METHODS: Ten healthy human volunteers were recruited for study participation. The data were recorded using a 128-channel electroencephalograph during baseline consciousness, subanesthetic dosing (0.5 mg/kg over 40 min), anesthetic dosing (1.5 mg/kg bolus), and recovery. No other sedative or anesthetic medications were administered. Spectrograms, topomaps, and functional connectivity (weighted and directed phase lag index) were computed and analyzed. RESULTS: Frontal theta bandwidth power increased most dramatically during ketamine anesthesia (mean power ± SD, 4.25 ± 1.90 dB) compared to the baseline (0.64 ± 0.28 dB), subanesthetic (0.60 ± 0.30 dB), and recovery (0.68 ± 0.41 dB) states; P < 0.001. Gamma power also increased during ketamine anesthesia. Weighted phase lag index demonstrated theta phase locking within anterior regions (0.2349 ± 0.1170, P < 0.001) and between anterior and posterior regions (0.2159 ± 0.1538, P < 0.01) during ketamine anesthesia. Alpha power gradually decreased with subanesthetic ketamine, and anterior-to-posterior directed connectivity was maximally reduced (0.0282 ± 0.0772) during ketamine anesthesia compared to all other states (P < 0.05). CONCLUSIONS: Ketamine anesthesia correlates most clearly with distinct changes in the theta bandwidth, including increased power and functional connectivity. Anterior-to-posterior connectivity in the alpha bandwidth becomes maximally depressed with anesthetic ketamine administration, suggesting a dose-dependent effect.


Analgesics/pharmacology , Brain/drug effects , Electroencephalography/drug effects , Ketamine/pharmacology , Nervous System Physiological Phenomena/drug effects , Dose-Response Relationship, Drug , Humans , Reference Values
19.
Article En | MEDLINE | ID: mdl-29560920

BACKGROUND: Functional neuroimaging studies have examined the neural substrates of treatments for major depressive disorder (MDD). Low sample size and methodological heterogeneity, however, undermine the generalizability of findings from individual studies. We conducted a meta-analysis to identify reliable neural changes resulting from different modes of treatment for MDD and compared them with each other and with reliable neural functional abnormalities observed in depressed versus control samples. METHODS: We conducted a meta-analysis of studies reporting changes in brain activity (e.g., as indexed by positron emission tomography) following treatments with selective serotonin reuptake inhibitors (SSRIs), electroconvulsive therapy (ECT), or transcranial magnetic stimulation. Additionally, we examined the statistical reliability of overlap among thresholded meta-analytic SSRI, ECT, and transcranial magnetic stimulation maps as well as a map of abnormal neural function in MDD. RESULTS: Our meta-analysis revealed that 1) SSRIs decrease activity in the anterior insula, 2) ECT decreases activity in central nodes of the default mode network, 3) transcranial magnetic stimulation does not result in reliable neural changes, and 4) regional effects of these modes of treatment do not significantly overlap with each other or with regions showing reliable functional abnormality in MDD. CONCLUSIONS: SSRIs and ECT produce neurally distinct effects relative to each other and to the functional abnormalities implicated in depression. These treatments therefore may exert antidepressant effects by diminishing neural functions not implicated in depression but that nonetheless impact mood. We discuss how the distinct neural changes resulting from SSRIs and ECT can account for both treatment effects and side effects from these therapies as well as how to individualize these treatments.


Antidepressive Agents/therapeutic use , Brain/surgery , Depressive Disorder, Major/therapy , Electroconvulsive Therapy , Selective Serotonin Reuptake Inhibitors/therapeutic use , Electroconvulsive Therapy/methods , Female , Humans , Male , Nervous System Physiological Phenomena/drug effects , Reproducibility of Results , Selective Serotonin Reuptake Inhibitors/adverse effects , Transcranial Magnetic Stimulation/methods , Treatment Outcome
20.
J Vis Exp ; (117)2016 11 26.
Article En | MEDLINE | ID: mdl-27929455

Honey bees demonstrate astonishing learning abilities and advanced social behavior and communication. In addition, their brain is small, easy to visualize and to study. Therefore, bees have long been a favored model amongst neurobiologists and neuroethologists for studying the neural basis of social and natural behavior. It is important, however, that the experimental techniques used to study bees do not interfere with the behaviors being studied. Because of this, it has been necessary to develop a range of techniques for pharmacological manipulation of honey bees. In this paper we demonstrate methods for treating restrained or free-flying honey bees with a wide range of pharmacological agents. These include both noninvasive methods such as oral and topical treatments, as well as more invasive methods that allow for precise drug delivery in either systemic or localized fashion. Finally, we discuss the advantages and disadvantages of each method and describe common hurdles and how to best overcome them. We conclude with a discussion on the importance of adapting the experimental method to the biological questions rather than the other way around.


Bees , Social Behavior , Animals , Nervous System/drug effects , Nervous System Physiological Phenomena/drug effects
...